Federal record
FDA Warning Letter issued April 8, 2025 · FDA closed it out on March 23, 2026. Read the FDA letter → Read the close-out letter →
Significant concerns: This provider has significant transparency or compliance concerns based on available public records. Evaluate the compliance data below before engaging their services.
Medivant Health
Phoenix, AZ
Is this your company? Claim this profile.
Medivant Health is a compounding pharmacy. The FDA issued a warning letter involving Medivant Health on April 8, 2025, closed out on March 23, 2026. Pricing was not publicly listed, so total cost should be confirmed before signing up.
What they offerCompounding Pharmacy
Why this score?
The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.
| 85-100 | High Confidence |
| 70-84 | Well Documented |
| 50-69 | Limited Confidence |
| 0-49 | Flagged |
Medivant Health scores 45, in the Flagged band. The score moves when the public record changes. For Medivant Health, the item most likely to move it: Pricing.
Payment never changes a score.
5 of 7 checks complete. The remaining checks have not been run yet. Missing checks reduce how complete the profile is. They are not a finding by themselves.
Score history
- 45September 2026Record updated
- 44August 2026Record updated
- 64June 2026Record updated
- 56June 2026Record updated
- 71June 2026Vial scoring update
- 58May 2026Record updated: enforcement record
What we found on Medivant Health
We reviewed FDA enforcement records, OIG exclusions, DEA registration, HIPAA breach records, NPI registration, PCAB accreditation, and FDA 503B registration.
The FDA issued a warning letter involving Medivant Health on April 8, 2025, and closed it out on March 23, 2026. Read the details below. We could not independently verify a third-party certification or accreditation as of October 2026.
Why this score: 5 of 7 checks complete. Each links to the public source it was verified against.
A check we haven’t completed yet is not a mark against this provider. It just means we’re still sourcing that record. The score reflects what we’ve confirmed so far, and updates as more checks come in.
Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed October 1, 2026.
Worth asking before you choose
Ask these before you sign up.
- 1What changed after the FDA warning letter?
- 2Has FDA issued a close-out letter?
- 3Are you operating as a 503A pharmacy or a 503B outsourcing facility?
- 4Which states are you licensed to ship to?
- 5Can you provide current state pharmacy license details?
See all 5 questionsShow fewer
Screenshot these or show your doctor: they’re the same questions Vial would ask.
Compare record details
Medivant Health scores 45, Belmar Compounding Pharmacy (formerly Women's International Pharmacy) scores 78.
| Medivant Health | Belmar Compounding Pharmacy (formerly Women's International Pharmacy) | |
|---|---|---|
| Federal actions | Confirmed | None found |
| Vial Score | 45/100 | 78/100 |
| LegitScript certified | No | No |
| PCAB accredited | No | No |
What Vial measures, and what we don’t
We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.
Other compounding pharmacy providers in Vial
Other Compounding Pharmacy in Vial’s directory. Open a profile, or compare side by side.
See 2 more alternativesShow fewer
Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.
Find your providerMore compounding pharmacy providers
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.